3. Summary of Significant Accounting Policies (Tables)

9 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of antidilutive shares

	December 31,
	2019		2018
Restricted stock units		2,000		4,000
Options to purchase common stock		358,000		160,000
Warrants to purchase common stock		468,000		468,000
Series C		17,000		17,000
Common Stock Units (1)		46,000		46,000
		891,000		695,000

 ______________

(1) Consists of 30,668 restricted stock units and warrants to purchase 15,332 shares of common stock

Disaggregated Revenue by Source

	Three Months Ended December 31,				Nine Months Ended December 31,
	2019		2018		2019		2018
Product
Human Skin Care	$	3,528,000	$	4,497,000	$	11,290,000	$	12,125,000
Animal Skin Care		853,000		548,000		2,188,000		1,650,000
		4,381,000		5,045,000		13,478,000		13,775,000
Service		297,000		235,000		879,000		813,000
Total	$	4,678,000	$	5,280,000	$	14,357,000	$	14,588,000